Bellerophon Therapeutics Announces FDA Clears Initiation of Phase 3 Study for INOpulse Inhaled Nitric Oxide Therapy to Treat COVID-19
Bellerophon Therapeutics, Inc., a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary and infectious lung diseases, announced that the U.S. FDA accepted its...
Enhertu granted Breakthrough Therapy Designation in the US for HER2-positive metastatic gastric cancer
AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo)’s Enhertu (trastuzumab deruxtecan) has been granted Breakthrough Therapy Designation (BTD) in the US for the treatment...
Abbott Earns Emergency Use Authorization for Another COVID-19 Antibody Test
Abbott Laboratories has won Emergency Use Authorization for another COVID-19-related diagnostics test for antibodies. This morning, the company said the U.S. FDA approved its...
FDA Approves Eli Lilly Precision Oncology Treatment for Certain Lung and Thyroid Cancers
Eli Lilly is moving quickly to get a newly-approved precision oncology treatment for certain lung and thyroid cancers into the hands of patients.
Following U.S....
Thermo Fisher Scientific Announces SARS-CoV-2 GlobalAccess Sequencing Program
To accelerate national, multi-institutional efforts focused on mapping coronavirus transmission and epidemiological studies, Thermo Fisher Scientific announces the SARS-CoV-2 GlobalAccess Sequencing Program for research...
Sterling Pharma Solutions commence the production of potential COVID-19 treatment
Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has commenced production of hydroxychloroquine (HCQ), a treatment currently under investigation for COVID-19.
Sterling will...
CoVIg-19 Plasma Alliance: International Organizations Work on Globulin Therapy for COVID-19
To date, 10 plasma companies globally have joined the CoVIg-19 Plasma Alliance, founded to accelerate development of a plasma-derived hyperimmune globulin therapy against COVID-19....
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...